Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia
NCT00369174
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
25
Enrollment
NIH
Sponsor class
Conditions
Oral Leukoplakia
Interventions
DRUG:
rosiglitazone maleate
OTHER:
laboratory biomarker analysis
Sponsor
National Cancer Institute (NCI)